[This review was originally posted at the Nieman Journalism Lab Buy Bactrim No Prescription, on April 6, 2012.]
Are read-it-later programs fair to publishers?: A brief controversy involving the offline reading app Readability brought to light some of the conflicts between publishers and those who present their content this week. It started last Friday, when Andy Faust of AppAdvice noticed that when Readability presents an article that you’ve saved to read later, it gives it to you from its own servers, without any prominent links to the original source. Daring Fireball’s John Gruber picked up the story and called Readability “scumbags” who “steal page views,” later saying his problem with Readability was that it presented its arrangement with publishers in dishonest terms, after Bactrim. ReadWriteWeb’s Jon Mitchell chimed in to warn that Readability and other apps like it are walking a fine line between useful tool and unfair middleman.
One of the larger underlying issues to this fight is nature of Readability’s model — as Mitchell explained, it’s free with an optional paid version, and it distributes a portion of the revenues proportionally among the publishers whose articles are saved, but only if they sign up to receive it. Make sense, Buy Bactrim No Prescription. Discount Bactrim, Good.
Readability responded to this criticism by adding direct links to the original publisher’s site and by reasserting the value of its financial model, particularly the fact that it pays some of the publishers of the content that gets shared on its apps. (This was something that online campaign organizer Clay Johnson also emphasized.) Anil Dash, a Readability adviser, offered a defense of the company, arguing that the tech world drags itself down with pointless inter-company squabbles, buy Bactrim online no prescription, and tech pioneer Dave Winer also said the whole thing is being blown out of proportion. Tech writer Ben Brooks countered Dash by saying that the issues surrounding Readability are big ones, particularly what happens to its unclaimed money. Buy Bactrim No Prescription, There were a few bigger-picture takes worth checking out on this issue. GigaOM’s Mathew Ingram wondered why publishers don’t take advantage of Readability’s program (or at least design a competitor), and ReadWriteWeb’s Mitchell wrote that while publishers shouldn’t be happy with Readability and Instapaper’s models, Buy Bactrim without a prescription, the primary onus is on them to give readers what they want: “If publishers want to stem the tide of impressions and money lost to read-later services, their sites need to not suck.” Newsvine CEO Mike Davidson made a similar point, saying that “this whole episode is a good reminder that the problems of the publishing industry haven’t gone away just because the world has gone digital. In fact, personal archiving is an example of a way it’s gotten worse.”
News Corp. takes another hit: As News Corp.’s phone-hacking scandal shifts toward bribery and, most recently, Bactrim photos, satellite piracy, Capital New York’s Tom McGeveran explained what this new scandal is and why it may be more damaging than the original one. Meanwhile, the News Corp. empire suffered another blow, as Rupert Murdoch’s son, James, resigned as chairman of BSkyB, the company’s largest broadcasting arm, just six weeks after he did the same thing with its British newspaper division, News International, Buy Bactrim No Prescription.
Several journalists helped us understand what the move means: NPR’s David Folkenflik highlighted the importance of BSkyB to the Murdoch empire, Bactrim without prescription, and the Guardian’s Dan Sabbagh explained that News Corp. is doing everything it can to keep BSkyB immune from its scandals. The BBC’s Robert Peston said James Murdoch’s resignation was voluntary and wasn’t prompted by the upcoming government report on the phone-hacking scandal, and Murdoch biographer Michael Wolff gave the backstory of the politics between Rupert and James Murdoch.
Elsewhere, a group of investors filed a formal call to replace Rupert Murdoch as News Corp. Buy Bactrim No Prescription, chairman with an independent official, and it appears as though Rupert and James will be called to testify before the hacking scandal inquiry in the next few weeks. In the Guardian, Bactrim recreational, Michael Wolff decried the American media’s apathy toward the scandals, and in an interesting tangential story, the document annotation and sharing site DocumentCloud took down the documents that broke the satellite piracy scandal because of a legal threat.
Philly papers’ startling price drop: Two of America’s iconic newspapers were sold again this week, and for many observers, Bactrim no rx, it was a reminder of how far the industry has fallen. The Philadelphia Media Network, which publishes the Philadelphia Inquirer, Philadelphia Daily News, and their shared website Philly.com, was sold for the fourth time in six years to a small group of investors that includes a few prominent local political figures.
The group had most prominently included former Philadelphia mayor and Pennsylvania governor Ed Rendell, Bactrim without a prescription, but he backed off after many people (including inside the papers’ newsrooms) voiced concern about possible political meddling. The Inquirer has the most comprehensive story on the sale, in which the new owners said they don’t want to run the papers, but simply want to preserve them for the community’s benefit, Buy Bactrim No Prescription. The new owners also voiced to Poynter their commitment to invest more money into the paper, met with employees to try to reassure them, and brought back former editor Bill Marimow, who is known for his commitment to investigative journalism. Buying Bactrim online over the counter, What got most people’s attention, though, was the price — $55 million. That’s barely 10 percent of the papers’ 2006 sale price, and the same price they were sold for in 1969. Both media analyst Alan Mutter and Forbes’ Brian Solomon remarked on the massive loss in value and detailed what went wrong.
Darts and laurels in Trayvon Martin coverage: A few notes on the ongoing story of Trayvon Martin’s killing: Pew’s Project for Excellence in Journalism released a report Buy Bactrim No Prescription, on how traditional media and social media have looked at the story, and it had a few interesting takeaways. First, Bactrim images, the story didn’t hit the public consciousness until a couple of weeks after the incident — but when it did, it blew up almost immediately. Second, blogs focused on racial aspects of the story, while Twitter was dominated by outrage at Zimmerman, Bactrim long term, and cable news and talk radio were focused on gun control and legal issues. And finally, there’s been a great disparity in the amount of coverage among the cable channels — tons on MSNBC, some on CNN, and much less on Fox News.
The New York Times’ David Carr lamented the sorry state of discourse surrounding the story, asking, order Bactrim from United States pharmacy, “What happened to the village common, a place where we all meet with different opinions but the same set of facts. It seems to have gone missing.” The Atlantic’s Elspeth Reeve pushed back against his complaints, Buy Bactrim No Prescription. Meanwhile, the Columbia Journalism Review published a remarkably comprehensive guide to the best journalism on the case, and critiqued the Orlando Sentinel’s coverage. Buy no prescription Bactrim online,
— Less than a year into their relationship, the liberal cable channel Current TVfired former MSNBC anchor Keith Olbermann late last week. Here’s Olbermann’s response, the emails that led up to the decision, and David Carr’s explanation of why Olbermann will get hired again by someone.
— A couple of interesting studies, doses Bactrim work, one on the production end and one on the consumption end: The American Society of News Editors released its annual survey of newsroom employment, and Poynter and Alan Mutter put the numbers in context regarding diversity and newsroom contraction, respectively. The other was a Pew study on e-reading Buy Bactrim No Prescription, , helpfully interpreted by Amy Gahran at CNN and Megan Garber of The Atlantic.
— Two interesting entries in Findings’ series on the future of reading: Wired columnist Clive Thompson, who generated smart responses from Robin Sloan and GigaOM’s Mathew Ingram, and NYU prof Clay Shirky, who also spoke with the Guardian about open journalism last weekend in a video that’s now up in snippets and in full.
— One of the leading groups representing the magazine industry announced guidelines for collecting user data on tablets. Here are the reports on the new standards from The New York Times and Adweek. And the American Journalism Review ran a feature on tablets as the big second chance for news orgs that have blown the transition to digital media.
— A few particularly helpful resources this week: At PBS MediaShift, Josh Stearns has written two parts of a guide to news media collaboration, and Journalism.co.uk has a great how-to on verifying information from social media.
— And two longer pieces to ponder: A Lab article highlighting a new paper identifying 27 computing concepts that could apply to journalism, and an engrossing interview by The Verge of The New York Times’ David Carr. Both are well worth your time this weekend.
Similar posts: Purchase Armour. Cephalexin Over The Counter. Armour Mg. Flagyl dangers. Herbal Diflucan. Order Tramadol no prescription.
Trackbacks from: Buy Bactrim No Prescription. Buy Bactrim No Prescription. Buy Bactrim No Prescription. Purchase Bactrim online. Is Bactrim addictive. Doses Bactrim work.
[This review was originally posted at the Nieman Journalism Lab Purchase Glucophage, on July 18, 2011.]
News Corp.'s scandal keeps growing: Rupert Murdoch might have hoped News Corp.'s phone hacking scandal would die down when he closed the British tabloid News of the World last week, but it only served to fuel the issue's explosion. This past week, the scandal's collateral damage spread to News Corp.'s proposed takeover of the British broadcaster BSkyB: Faced with increasing pressure from the British government and the revelation that News Corp. journalists tried to get private records of former Prime Minister Gordon Brown, News Corp. dropped the BSkyB bid, which had been a huge part of the company's U.K. strategy. Buy no prescription Glucophage online, Plenty of other problems are cropping up for News Corp., too. The top lawyer for its U.K, Purchase Glucophage. newspaper branch, News International, quit. The company's stock lost $7 billion in four business days at one point. A pre-existing U.S. shareholders' suit expanded to cover the hacking scandal, is Glucophage addictive. The Murdochs have to testify before British Parliament Purchase Glucophage, this week about the scandal, and the FBI started investigating U.S.-related aspects of the issue. That's all in addition to the ongoing problems News Corp. faces, as detailed by Poynter's Rick Edmonds.
The scandal has led quite a few writers to criticize the culture that Murdoch has created at News Corp. Capital New York's Tom McGeveran and Reuters' John Lloyd railed on Murdoch and News Corp.'s character, Carl Bernstein called this Murdoch's Watergate, Canada, mexico, india, and the Observer's editorial board called for systemic reforms in Britain so Murdoch's influence can never be so strong. Members of the Bancroft family said they wouldn't have sold the Wall Street Journal to Murdoch in 2007 if they'd have known the hacking was going on, Purchase Glucophage.
On the other hand, the New York Times pointed out that sleazy British tabloid tactics are hardly limited to Murdoch, and media critic Howard Kurtz noted that they're very much alive in the U.S. mainstream press, too. New York Times columnist Roger Cohen defended Murdoch, saying he's been good for journalism on the whole, purchase Glucophage online, and Gawker's John Cook defended those tabloid reporting tactics. Meanwhile, j-prof Jeff Jarvis and the Telegraph's Toby Harnden urged the British government not to respond by enacting more regulation. Purchase Glucophage, News Corp.'s retreat might not stop with News of the World and BSkyB. Murdoch biographer Michael Wolff and others have reported that the company's execs are debating whether to get out of Britain's newspaper business entirely, and several observers chimed in to say that might actually make a good deal of business sense. Media analyst Ken Doctor said News International is losing steam, After Glucophage, and the Financial Times' John Gapper said newspapers are becoming far more trouble than they're worth to Murdoch.
Not only that, but the New Yorker's John Cassidy said dropping his U.K. newspapers could let Murdoch revive his BSkyB bid, and Jeff Jarvis speculated that when Murdoch chooses between the power that the papers give him and the money saved by getting rid of them, he'll choose the money. In an interview with the Wall Street Journal, Murdoch called the rumors of a newspaper sell-off "rubbish."
But just because News of the World and News International may be dead and dying, that doesn't mean newspapers as a whole are, argued David Carr of the New York Times, Purchase Glucophage. As he noted, it was the Guardian's dogged reporting that finally broke this story open. Murdoch "prefers his crusades to be built on chronic ridicule and bombast, Glucophage used for. But as The Guardian has shown, the steady accretion of fact — an exercise Mr. Murdoch has historically regarded as bland and elitist — can have a profound effect," Carr wrote. The Atlantic also had praise for the Guardian, and Poynter's Mallary Jean Tenore interviewed one of its editors about the lonely journey of covering the phone hacking story.
HuffPo aggregation under the microscope Purchase Glucophage, : A lively discussion about the rights and wrongs of aggregation developed last week out of a column by Ad Age media critic Simon Dumenco, who complained that the Huffington Post had extensively summarized one of his posts, buried the link to the original, and — contrary to Arianna Huffington's argument that her site benefits those they aggregate by sending them readers — gave him just 57 page views. Buy Glucophage without a prescription, The Huffington Post responded by apologizing and suspending the article's writer. HuffPo business editor Peter Goodman told Adweek the piece was a fully formed article when it should have been a simple introduction and a link, but Dumenco responded to the apology by arguing that the writer did nothing out of the ordinary — this is just how HuffPo tells its writers to do it.
Dumenco's point was echoed by several others: The Awl's Choire Sicha said the suspended writer was doing what she was taught, Gawker's Ryan Tate, drawing on a revealing quote from a former HuffPo writer, made the same point: "This is pretty ridiculous, given HuffPo's systematic, Glucophage dosage, officially-sanctioned approach to rewriting too much of people's news articles." British journalist Kevin Anderson called HuffPo's summary-heavy aggregation "a pretty cynical strategy," and paidContent's Staci Kramer said HuffPo needs to respect its sources, rather than treating a link as a favor.
Gabe Rivera, whose news site, Techmeme, Where can i order Glucophage without prescription, was compared to HuffPo favorably by Dumenco, looked for terms to distinguish what his site does from what HuffPo does. Poynter's Julie Moos said some measure of originality will always make for better journalism and a better business model than heavy aggregation, and ZDNet's Tom Foremski pined for the old blogging mentality whose goal was to add value, Purchase Glucophage. In a short podcast, author Steven Rosenbaum said this is a logical time to step back and evaluate exactly what constitutes ethical aggregation.
There were a few dissenters, though: GigaOM's Mathew Ingram and Slate's Jack Shafer both argued that the type of aggregation that HuffPo does has been around for ages in traditional media (especially in Britain, according to Forbes' Tim Worstall). In fact, Glucophage coupon, Shafer said, news orgs could learn a something valuable from the Huffington Post: "That a huge, previously ignored readership out there wants its news hot, quick, and tight."
Comparing Google+, Facebook, Cheap Glucophage, and Twitter: It's been just about three weeks since Google+ launched, and Google's new social network is growing like a weed, with estimates of as many as 10 million users so far. (Its number of active users may soon be approaching Twitter's figures.) Google+ news has dominated Twitter, and Google's also working on integrating it with Gmail. Purchase Glucophage, With Plus' incredible growth, tech observers have been going back and forth about what social network Google+ is disrupting most. PCWorld's Megan Geuss wondered whether Google+ and Facebook can coexist, and PC Magazine's John Dvorak posited that all the excitement about Google+ is more or less just pent-up frustration with Facebook. The New York Times' David Pogue and Technology Review's Paul Boutin both compared Google+ favorably to Facebook, largely because of its superior privacy controls (though GigaOM's Mathew Ingram pointed out that it may not be a privacy improvement for some people).
Meanwhile, Search Engine Land's Danny Sullivan said Google+ is more comparable to Twitter, Glucophage natural, then went ahead and made a thorough, smart comparison between the two. The Atlantic's Alexis Madrigal said Google+ might end up being more conversational than Twitter, which he called more of a call-and-response: Google+ "won't be as good at connecting people to information or each other quickly, but it might be better at longer form discussions and whatever we call the process by which people pull reasoned thoughts from their networks into public discourse." Hutch Carpenter said Google+ resembles both Facebook and Twitter, and Computer World's Mike Elgan wrote that it'll disrupt just about everything.
Still, Google+ has its limits: ReadWriteWeb's Marshall Kirkpatrick explained why he'd never move his personal blog there as some are doing, and Instapaper's Marco Arment and the Guardian's Dan Gillmor both urged readers to keep a space for their own online identity outside of spaces like Google+ or Facebook, Purchase Glucophage. For journalists feeling out Google+, Meranda Watling of 10, Glucophage from canada,000 Words put together a preliminary guide.
Reading roundup: Here's what else people were talking about this past week:
— The newspaper chain MediaNews made a distinctive play for the tablet news market last week, announcing the launch of TapIn, a location-based news app made specifically for tablets. It'll start in the Bay Area in partnership with the San Jose Mercury News. Ken Doctor, Jeff Sonderman, Glucophage overnight, and Mathew Ingram all wrote about what makes it worth watching.
— The Economist continued running pieces all week in its series on the future of the news industry. You can check out several writers'reasons for optimism or read the opening statements in an ongoing debate between NYU's Jay Rosen and author Nicholas Carr about whether the Internet has been good for journalism.
— Boston Globe developer Andy Boyle made his pitch for young journalists to go into web development, or as he put it, "learn to make the internets."
— Finally, NYU's Clay Shirky gave us another thoughtful essay on the unbundling of news and why the news ecosystem needs to be chaotic right now. In the end, though, here's what he believes news should be: "News has to be subsidized because society’s truth-tellers can’t be supported by what their work would fetch on the open market"; "news has to be cheap because cheap is where the opportunity is right now"; and "news has to be free, because it has to spread.".
Similar posts: Zoloft No Rx. Bactrim For Sale. Glucophage Price. Tramadol coupon. Glucophage for sale. Cephalexin reviews.
Trackbacks from: Purchase Glucophage. Purchase Glucophage. Purchase Glucophage. Glucophage dose. Buying Glucophage online over the counter. Rx free Glucophage.